Articaine API from Belgium Manufacturers & Suppliers

Articaine (CAS 23964-58-1) is an amide-type local anesthetic used primarily for dental anesthesia. It is widely adopted in clinical dental practice and is the predominant local anesthetic agent in several European markets. Structurally, it is classified among thiophene carboxylic acid derivatives, incorporating a thiophene ring that contributes to its physicochemical profile.

The clinical use of articaine centers on achieving local infiltration or nerve block anesthesia for dental procedures. Its onset is rapid, and it provides a depth of anesthesia suitable for routine and complex dental interventions. As with other amide local anesthetics, its primary pharmacological action is the reversible inhibition of voltage-gated sodium channels in peripheral sensory nerves, preventing impulse conduction and producing localized loss of sensation.

Articaine exhibits high lipid solubility, supporting effective tissue penetration. After systemic absorption, it undergoes rapid hydrolysis by plasma esterases due to its unique ester side chain, leading to comparatively faster systemic clearance than many other amide anesthetics. Hepatic metabolism contributes to further biotransformation, and renal excretion accounts for elimination of metabolites.

Safety considerations include dose-dependent central nervous system and cardiovascular effects typical of local anesthetics, such as CNS excitation or depression and potential hemodynamic changes when systemic levels become elevated. Rare events such as methemoglobinemia have been reported. Articaine is commonly formulated with epinephrine to limit systemic absorption and prolong local effect, and commercially it is available under names such as Septocaine and Ubistesin.

For API procurement, sourcing should focus on suppliers with demonstrated control of stereochemistry, impurity profiles, and residual solvent levels, supported by comprehensive regulatory documentation and adherence to internationally recognized GMP standards.